Gleason 4+4=8 & Hormone Therapy | Ask a Prostate Cancer Expert, Mark Scholz, MD


PCRI's CEO, Alex Scholz, asks medical oncologist, Mark Scholz, MD, about hormone therapy alongside radiation therapy for men with Gleason 4+4=8 prostate cancer.

0:05 Why is hormone therapy beneficial for men undergoing radiation for Gleason 8?

1:38 What hormone therapies are used for Gleason 4+4=8?

2:52 Do most oncologists prescribe a second-generation hormonal agent as an initial treatment?

4:04 Does hormone therapy happen before or after radiation?

5:08 Typically, what types of radiation are used for Gleason 4+4=8?

5:40 What should a patient's PSA be after treatment and in what time frame?

6:54 How long do PSA bumps last?

7:16 How often do men need to have scans during a PSA bump?

Donโ€™t know your stage? Take the quiz: Visit

To learn more about prostate cancer visit

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next